MAP1LC3A and inclusion body myositis: Hiniker Hiniker A A Daniels Daniels BH BH Lee Lee HS HS Margeta Margeta M M Comparative Utility of LC3, P62 and TDP-43 Immunohistochemistry in Differentiation of Inclusion Body Myositis from Polymyositis and Related Inflammatory Myopathies Comparative Utility of LC3, P62 and TDP-43 Immunohistochemistry in Differentiation of Inclusion Body Myositis from Polymyositis and Related Inflammatory Myopathies Acta neuropathol commun Acta neuropathol commun 2013 2013 1 1 29 29 10.1186/2051-5960-1-29 10.1186/2051-5960-1-29 supplied-pmid 24252466?